{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:15:51Z","timestamp":1762542951018,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ajo.2018.09.033","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T02:49:28Z","timestamp":1539053368000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Histoplasmosis Following Systemic Immunomodulatory Therapy for Ocular Inflammation"],"prefix":"10.1016","volume":"198","author":[{"given":"Matthew R.","family":"Starr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2018.09.033_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3201\/eid1709.101987","article-title":"Geographic distribution of endemic fungal infections among older persons, United States","volume":"17","author":"Baddley","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2018.09.033_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198001000-00001","article-title":"Disseminated histoplasmosis: clinical and pathologic correlations","volume":"59","author":"Goodwin","year":"1980","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.ajo.2018.09.033_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9610(79)90050-3","article-title":"Disseminated histoplasmosis in renal transplant recipients","volume":"137","author":"Davies","year":"1979","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.ajo.2018.09.033_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9343(78)90445-X","article-title":"Histoplasmosis in immunosuppressed patients","volume":"64","author":"Kauffman","year":"1978","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ajo.2018.09.033_bib5","doi-asserted-by":"crossref","first-page":"ofu116","DOI":"10.1093\/ofid\/ofu116","article-title":"Histoplasmosis in patients with cell-mediated immunodeficiency: human immunodeficiency virus infection, organ transplantation, and tumor necrosis factor-alpha inhibition","volume":"2","author":"Luckett","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajo.2018.09.033_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2334-11-145","article-title":"Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009","volume":"11","author":"Olson","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.033_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2018.09.033_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10792-011-9459-3","article-title":"Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy","volume":"31","author":"Lim","year":"2011","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2018.09.033_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fimmu.2014.00432","article-title":"T cell-macrophage interactions and granuloma formation in vasculitis","volume":"5","author":"Hilhorst","year":"2014","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ajo.2018.09.033_bib10","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.4049\/jimmunol.152.12.5883","article-title":"Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1","volume":"152","author":"Lukacs","year":"1994","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.033_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-84-3-304","article-title":"Glucocorticosteroid therapy: mechanisms of action and clinical considerations","volume":"84","author":"Fauci","year":"1976","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ajo.2018.09.033_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM197501302920504","article-title":"Effects of corticosteroid therapy on human monocyte function","volume":"292","author":"Rinehart","year":"1975","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2018.09.033_bib13","first-page":"156","article-title":"Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors","volume":"68","author":"Horst","year":"1987","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2018.09.033_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2008.10.003","article-title":"Cytokine related therapies for autoimmune disease","volume":"20","author":"Strom","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.ajo.2018.09.033_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/keg323","article-title":"Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis","volume":"42","author":"Gerards","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ajo.2018.09.033_bib16","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ajo.2018.09.033_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00027-06","article-title":"Histoplasmosis: a clinical and laboratory update","volume":"20","author":"Kauffman","year":"2007","journal-title":"Clin Microbiol Rev"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:38:04Z","timestamp":1757597884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418305750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":17,"alternative-id":["S0002939418305750"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.09.033","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histoplasmosis Following Systemic Immunomodulatory Therapy for Ocular Inflammation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}